{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:27:23Z","timestamp":1787318843310,"version":"build-2736575974"},"reference-count":37,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"\n OBJECTIVE<\/jats:title>\n De novo seizure following craniotomy (DSC) for nontraumatic pathology may adversely affect medical and neurological outcomes in patients with no history of seizures who have undergone craniotomies. Antiepileptic drugs (AEDs) are commonly used prophylactically in patients undergoing craniotomy; however, evidence supporting this practice is limited and mixed. The authors aimed to collate the available evidence on the efficacy and tolerability of levetiracetam monotherapy and compare it with that of the classic AED, phenytoin, for DSC.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n PubMed, Embase, Web of Science, and the Cochrane Library were searched for studies that compared levetiracetam with phenytoin for DSC prevention. Inclusion criteria were adult patients with no history of epilepsy who underwent craniotomy with prophylactic usage of phenytoin, a comparator group with levetiracetam treatment as the main treatment difference between the two groups, and availability of data on the numbers of patients and seizures for each group. Patients with brain injury and previous seizure history were excluded. DSC occurrence and adverse drug reaction (ADR) were evaluated. Seizure occurrence was calculated using the Peto odds ratio (POR), which is the relative effect estimation method of choice for binary data with rare events.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n Data from 7 studies involving 803 patients were included. The DSC occurrence rate was 1.26% (4\/318) in the levetiracetam cohort and 6.60% (32\/485) in the phenytoin cohort. Meta-analysis showed that levetiracetam is significantly superior to phenytoin for DSC prevention (POR 0.233, 95% confidence interval [CI] 0.117\u20130.462, p < 0.001). Subgroup analysis demonstrated that levetiracetam is superior to phenytoin for DSC due to all brain diseases (POR 0.129, 95% CI 0.039\u20130.423, p = 0.001) and tumor (POR 0.282, 95% CI 0.117\u20130.678, p = 0.005). ADRs in the levetiracetam group were cognitive disturbance, thrombophlebitis, irritability, lethargy, tiredness, and asthenia, whereas rash, anaphylaxis, arrhythmia, and hyponatremia were more common in the phenytoin group. The overall occurrence of ADR in the phenytoin (34\/466) and levetiracetam (26\/432) groups (p = 0.44) demonstrated no statistically significant difference in ADR occurrence. However, the discontinuation rate of AEDs due to ADR was 53\/297 in the phenytoin group and 6\/196 in the levetiracetam group (POR 0.266, 95% CI 0.137\u20130.518, p < 0.001).<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Levetiracetam is superior to phenytoin for DSC prevention for nontraumatic pathology and has fewer serious ADRs that lead to discontinuation. Further high-quality studies that compare levetiracetam with placebo are necessary to provide evidence for establishing AED guidelines.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2018.4.jns1891","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T09:57:07Z","timestamp":1531475827000},"page":"2063-2070","source":"Crossref","is-referenced-by-count":12,"title":["Phenytoin versus levetiracetam as prophylaxis for postcraniotomy seizure in patients with no history of seizures: systematic review and meta-analysis"],"prefix":"10.3171","volume":"130","author":[{"given":"Chang-Hyun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Seoul National University Hospital, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Won","family":"Koo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neuroscience & Radiosurgery Hybrid Research Center, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Rok","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ilsan Paik Hospital, Inje University College of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ilsan Paik Hospital, Inje University College of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Jun","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neuroscience & Radiosurgery Hybrid Research Center, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Heuck","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ilsan Paik Hospital, Inje University College of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Neurosciences (Riyadh)","doi-asserted-by":"publisher","first-page":"107","DOI":"10.17712\/nsj.2017.2.20160570","article-title":"Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection","volume":"22","author":"Al-Dorzi HM","year":"2017","unstructured":"Al-Dorzi HM, Alruwaita AA, Marae BO, Alraddadi BS, Tamim HM, Ferayan A, : Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection. Neurosciences (Riyadh) 22:107\u2013113, 20172841678110.17712\/nsj.2017.2.20160570"},{"key":"b2","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/neuonc\/noq044","article-title":"Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide","volume":"12","author":"Bobustuc GC","year":"2010","unstructured":"Bobustuc GC, Baker CH, Limaye A, Jenkins WD, Pearl G, Avgeropoulos NG, : Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro Oncol 12:917\u2013927, 201010.1093\/neuonc\/noq04420525765"},{"key":"b3","series-title":"Biom J","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/bimj.201600034","article-title":"Performance of the Peto odds ratio compared to the usual odds ratio estimator in the case of rare events","volume":"58","author":"Brockhaus AC","year":"2016","unstructured":"Brockhaus AC, Grouven U, Bender R: Performance of the Peto odds ratio compared to the usual odds ratio estimator in the case of rare events. Biom J 58:1428\u20131444, 20162754648310.1002\/bimj.201600034"},{"key":"b4","series-title":"BMC Health Serv Res","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1472-6963-3-23","article-title":"Can surveying practitioners about their practices help identify priority clinical practice guideline topics?","volume":"3","author":"Brouwers MC","year":"2003","unstructured":"Brouwers MC, Chambers A, Perry J: Can surveying practitioners about their practices help identify priority clinical practice guideline topics? BMC Health Serv Res 3:23, 200310.1186\/1472-6963-3-2314687426"},{"key":"b5","series-title":"Drugs Today (Barc)","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1358\/dot.2007.43.11.1136902","volume":"43","author":"Carreno M","year":"2007","unstructured":"Carreno M: Levetiracetam. Drugs Today (Barc) 43:769\u2013794, 200710.1358\/dot.2007.43.11.113690218174964"},{"key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3171\/2016.4.JNS16245","article-title":"Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS\/CNS Section on Tumors survey","volume":"126","author":"Dewan MC","year":"2017","unstructured":"Dewan MC, Thompson RC, Kalkanis SN, Barker FG II, Hadjipanayis CG: Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS\/CNS Section on Tumors survey. J Neurosurg 126:1772\u20131778, 201710.3171\/2016.4.JNS1624527341048"},{"key":"b7","series-title":"Neurocirugia (Astur)","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neucir.2011.12.002","article-title":"[Primary prophylaxis of early seizures after surgery of cerebral supratentorial tumors: Group for the Study of Functional-Sterotactic Neurosurgery of The Spain Society of Neurosurgery recommendations.]","volume":"23","author":"Dom\u00ednguez-P\u00e1ez M","year":"2012","unstructured":"Dom\u00ednguez-P\u00e1ez M, Herranz-Fern\u00e1ndez JL, Villanueva-Haba V, S\u00e1nchez-\u00c1lvarez JC, Olivares-Granados G, Sola RG, : [Primary prophylaxis of early seizures after surgery of cerebral supratentorial tumors: Group for the Study of Functional-Sterotactic Neurosurgery of The Spain Society of Neurosurgery recommendations.] Neurocirugia (Astur) 23:29\u201335, 201210.1016\/j.neucir.2011.12.002"},{"issue":"Suppl 1","key":"b8","series-title":"Epilepsy Curr","first-page":"1.273","article-title":"Side effects and tolerability of IV levetiracetam vs. IV phenytoin and follow-on oral regimens in a neurosurgical patient population: a prospective randomised study","volume":"11","author":"D\u2019Souza W","year":"2011","unstructured":"D\u2019Souza W, Fuller K, Murphy M, Cook MJ: Side effects and tolerability of IV levetiracetam vs. IV phenytoin and follow-on oral regimens in a neurosurgical patient population: a prospective randomised study. Epilepsy Curr 11 (Suppl 1): 1.273, 2011"},{"key":"b9","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF01808441","article-title":"The incidence of postoperative seizures","volume":"55","author":"Foy PM","year":"1981","unstructured":"Foy PM, Copeland GP, Shaw MD: The incidence of postoperative seizures. Acta Neurochir (Wien) 55:253\u2013264, 1981723453110.1007\/BF01808441"},{"key":"b10","series-title":"Epilepsia","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1528-1167.2012.03563.x","article-title":"Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study","volume":"54","author":"Fuller KL","year":"2013","unstructured":"Fuller KL, Wang YY, Cook MJ, Murphy MA, D\u2019Souza WJ: Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia 54:45\u201357, 20132273809210.1111\/j.1528-1167.2012.03563.x"},{"key":"b11","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","article-title":"Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"54","author":"Glantz MJ","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, : Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886\u20131893, 200010.1212\/WNL.54.10.188610822423"},{"key":"b12","series-title":"J Neurosurg Sci","article-title":"The risk of hypotension and seizures in patients receiving prophylactic anti-epileptic drugs for supratentorial craniotomy","author":"H\u00f6hne J","year":"[epub ahead of print], 2016","unstructured":"H\u00f6hne J, Schebesch KM, Ott C, Brawanski A, Lange M: The risk of hypotension and seizures in patients receiving prophylactic anti-epileptic drugs for supratentorial craniotomy. J Neurosurg Sci [epub ahead of print], 2016"},{"key":"b13","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/jnnp-2014-308584","article-title":"Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study","volume":"86","author":"Iuchi T","year":"2015","unstructured":"Iuchi T, Kuwabara K, Matsumoto M, Kawasaki K, Hasegawa Y, Sakaida T: Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study. J Neurol Neurosurg Psychiatry 86:1158\u20131162, 201510.1136\/jnnp-2014-30858425511789"},{"key":"b14","series-title":"Neurosurg Q","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/WNQ.0000000000000192","article-title":"Antiepileptic drug prophylaxis in unruptured intracranial aneurysms","volume":"26","author":"Kemerdere R","year":"2016","unstructured":"Kemerdere R, Kacira T, Ak H, Ozyurt E, Tanriverdi T: Antiepileptic drug prophylaxis in unruptured intracranial aneurysms. Neurosurg Q 26:325\u2013328, 201610.1097\/WNQ.0000000000000192"},{"key":"b15","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jocn.2011.07.021","article-title":"Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy","volume":"19","author":"Kern K","year":"2012","unstructured":"Kern K, Schebesch KM, Schlaier J, Hansen E, Feigl GC, Brawanski AT, : Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy. J Clin Neurosci 19:99\u2013100, 201210.1016\/j.jocn.2011.07.02122133815"},{"key":"b16","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","article-title":"Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study","volume":"93","author":"Lim DA","year":"2009","unstructured":"Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, : Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol 93:349\u2013354, 20091916965110.1007\/s11060-008-9781-4"},{"key":"b17","series-title":"Pharmacol Rev","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research","volume":"62","author":"L\u00f6scher W","year":"2010","unstructured":"L\u00f6scher W, Brandt C: Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 62:668\u2013700, 20102107904010.1124\/pr.110.003046"},{"key":"b18","series-title":"J Clin Pharm Ther","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.0269-4727.2003.00506.x","article-title":"Rapid i.v. loading with phenytoin with subsequent dose adaptation using non-steady-state serum levels and a Bayesian forecasting computer program to predict maintenance doses","volume":"28","author":"Martinelli EF","year":"2003","unstructured":"Martinelli EF, M\u00fchlebach SF: Rapid i.v. loading with phenytoin with subsequent dose adaptation using non-steady-state serum levels and a Bayesian forecasting computer program to predict maintenance doses. J Clin Pharm Ther 28:385\u2013393, 200310.1046\/j.0269-4727.2003.00506.x"},{"issue":"6 Suppl 1","key":"b19","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1212\/WNL.46.6_Suppl_1.8S","article-title":"Parenteral antiepileptic\/anticonvulsant drugs","volume":"46","author":"Mattson RH","year":"1996","unstructured":"Mattson RH: Parenteral antiepileptic\/anticonvulsant drugs. Neurology 46 (6 Suppl 1):S8\u2013S13, 199610.1212\/WNL.46.6_Suppl_1.8S"},{"key":"b20","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/01.wnl.0000324624.52935.46","article-title":"Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery","volume":"71","author":"Milligan TA","year":"2008","unstructured":"Milligan TA, Hurwitz S, Bromfield EB: Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 71:665\u2013669, 200810.1212\/01.wnl.0000324624.52935.4618725591"},{"key":"b21","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-016-2146-5","article-title":"Levetiracetam for seizure prevention in brain tumor patients: a systematic review","volume":"129","author":"Nasr ZG","year":"2016","unstructured":"Nasr ZG, Paravattil B, Wilby KJ: Levetiracetam for seizure prevention in brain tumor patients: a systematic review. J Neurooncol 129:1\u201313, 201610.1007\/s11060-016-2146-527168191"},{"key":"b22","series-title":"Proceedings of the 19th Cochrane Colloquium","first-page":"19","article-title":"Risk of bias assessment tool for non-randomized studies (RoBANS): development and validation of a new instrument","author":"Park J","year":"2011","unstructured":"Park J, Lee Y, Seo H, Jang B, Son H, Kim S: Risk of bias assessment tool for non-randomized studies (RoBANS): development and validation of a new instrument, in Proceedings of the 19th Cochrane Colloquium. London: Cochrane, 2011, pp 19\u201322"},{"key":"b23","series-title":"Br J Clin Pharmacol","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bcp.12926","article-title":"Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis","volume":"82","author":"Pourzitaki C","year":"2016","unstructured":"Pourzitaki C, Tsaousi G, Apostolidou E, Karakoulas K, Kouvelas D, Amaniti E: Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis. Br J Clin Pharmacol 82:315\u2013325, 201610.1111\/bcp.1292626945547"},{"key":"b24","series-title":"Epilepsia","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","article-title":"Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study","volume":"47","author":"Ramael S","year":"2006","unstructured":"Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, : Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 47:1128\u20131135, 20061688697510.1111\/j.1528-1167.2006.00586.x"},{"issue":"Suppl 4","key":"b25","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"iv55","DOI":"10.1093\/neuonc\/nos199","article-title":"Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments","volume":"14","author":"Rud\u00e0 R","year":"2012","unstructured":"Rud\u00e0 R, Bello L, Duffau H, Soffietti R: Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol 14 (Suppl 4):iv55\u2013iv64, 201210.1093\/neuonc\/nos199"},{"key":"b26","series-title":"Epilepsy Behav","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.yebeh.2008.01.004","article-title":"Intravenous levetiracetam: treatment experience with the first 50 critically ill patients","volume":"12","author":"R\u00fcegg S","year":"2008","unstructured":"R\u00fcegg S, Naegelin Y, Hardmeier M, Winkler DT, Marsch S, Fuhr P: Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 12:477\u2013480, 200810.1016\/j.yebeh.2008.01.00418291724"},{"key":"b27","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3171\/2014.7.JNS132829","article-title":"Anticonvulsant prophylaxis for brain tumor surgery: determining the current best available evidence","volume":"121","author":"Sayegh ET","year":"2014","unstructured":"Sayegh ET, Fakurnejad S, Oh T, Bloch O, Parsa AT: Anticonvulsant prophylaxis for brain tumor surgery: determining the current best available evidence. J Neurosurg 121:1139\u20131147, 201410.3171\/2014.7.JNS13282925170671"},{"key":"b28","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-004-6912-4","article-title":"Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors","volume":"74","author":"Siomin V","year":"2005","unstructured":"Siomin V, Angelov L, Li L, Vogelbaum MA: Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors. J Neurooncol 74:211\u2013215, 200510.1007\/s11060-004-6912-416193395"},{"key":"b29","series-title":"Mayo Clin Proc","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.4065\/77.12.1367","article-title":"Antiepileptic drug therapy for adults: when to initiate and how to choose","volume":"77","author":"Sirven JI","year":"2002","unstructured":"Sirven JI: Antiepileptic drug therapy for adults: when to initiate and how to choose. Mayo Clin Proc 77:1367\u20131375, 20021247952710.4065\/77.12.1367"},{"key":"b30","series-title":"Mayo Clin Proc","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.4065\/79.12.1489","article-title":"Seizure prophylaxis in patients with brain tumors: a meta-analysis","volume":"79","author":"Sirven JI","year":"2004","unstructured":"Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS: Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79:1489\u20131494, 20041559533110.4065\/79.12.1489"},{"key":"b31","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ana.24522","article-title":"Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: a retrospective observational single center study","volume":"78","author":"Skardelly M","year":"2015","unstructured":"Skardelly M, Brendle E, Noell S, Behling F, Wuttke TV, Schittenhelm J, : Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: a retrospective observational single center study. Ann Neurol 78:917\u2013928, 201510.1002\/ana.2452226385488"},{"key":"b32","series-title":"Epilepsy Curr","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1046\/j.1535-7597.2002.00038.x","article-title":"Prophylactic anticonvulsants after neurosurgery","volume":"2","author":"Temkin NR","year":"2002","unstructured":"Temkin NR: Prophylactic anticonvulsants after neurosurgery. Epilepsy Curr 2:105\u2013107, 200210.1046\/j.1535-7597.2002.00038.x15309132"},{"key":"b33","series-title":"Cochrane Database Syst Rev (2)","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004424.pub2","article-title":"Antiepileptic drugs for preventing seizures in people with brain tumors","author":"Tremont-Lukats IW","year":"2008","unstructured":"Tremont-Lukats IW, Ratilal BO, Armstrong T, Gilbert MR: Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev (2):CD004424, 200810.1002\/14651858.CD004424.pub2"},{"key":"b34","series-title":"Cochrane Database Syst Rev (3)","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007286.pub3","article-title":"Antiepileptic drugs as prophylaxis for post-craniotomy seizures","author":"Weston J","year":"2015","unstructured":"Weston J, Greenhalgh J, Marson AG: Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev (3):CD007286, 201510.1002\/14651858.CD007286.pub3"},{"key":"b35","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3171\/2012.12.JNS111970","article-title":"A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors","volume":"118","author":"Wu AS","year":"2013","unstructured":"Wu AS, Trinh VT, Suki D, Graham S, Forman A, Weinberg JS, : A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 118:873\u2013883, 201310.3171\/2012.12.JNS11197023394340"},{"key":"b36","series-title":"Seizure","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.seizure.2014.04.016","article-title":"P450 enzyme-inducing and non-enzyme-inducing antiepileptic drugs for seizure prophylaxis after glioma resection surgery: a meta-analysis","volume":"23","author":"Yuan Y","year":"2014","unstructured":"Yuan Y, Yunhe M, Xiang W, Yanhui L, Yanwu Y, Shuang L, : P450 enzyme-inducing and non-enzyme-inducing antiepileptic drugs for seizure prophylaxis after glioma resection surgery: a meta-analysis. Seizure 23:616\u2013621, 201410.1016\/j.seizure.2014.04.01624878104"},{"key":"b37","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11060-010-0235-4","article-title":"Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery","volume":"101","author":"Zachenhofer I","year":"2011","unstructured":"Zachenhofer I, Donat M, Oberndorfer S, Roessler K: Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery. J Neurooncol 101:101\u2013106, 201110.1007\/s11060-010-0235-420526797"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/130\/6\/article-p2063.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/130\/6\/article-p2063.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/130\/6\/article-p2063.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T03:17:59Z","timestamp":1679800679000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/130\/6\/article-p2063.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2018.4.jns1891","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}